June 24, 2020 — During the height of the COVID-19 pandemic in New York City, health care workers on the front lines had high levels of acute stress, anxiety, and depression, a study by researchers at Columbia University Irving Medical Center and NewYork-Presbyterian has found.

June 23, 2020 — An innovative use of focused ultrasound being pioneered at the University of Virginia School of Medicine is showing promise against glioblastoma, the deadliest brain tumor, and could prove useful against other difficult-to-treat cancers.

June 23, 2020 — On June 23, 2020, Stephen M. Hahn, M.D., Commissioner of Food and Drugs, released a statement regarding the United States Food and Drug Administration (FDA) maintaining the pace of meeting its goals on applications for medical products during the pandemic. Hahn stated:

June 22, 2020 — Chronic traumatic encephalopathy (CTE), a neurodegenerative disease caused by repeated head injuries often affecting athletes, can only be diagnosed currently through brain tissue analysis post-mortem.

June 19, 2020 — Imaging Biometrics, LLC (IB), a subsidiary of IQ-AI Limited and a recognized leader in quantitative imaging analysis for brain tumor diagnosis and treatment, today announced that the MRI DSC perfusion technology, first made commercially available in IB Neuro, earned recognition as the national standard for use in high-grade brain tumors.

June 18, 2020 — QuEST Global, a global product engineering and lifecycle services company, announced that it has developed a robust artificial intelligence (AI)-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms. Using advanced deep learning models, the AI-powered diagnostic solution can sort and identify chest X-rays of patients with COVID-19.

June 18, 2020 — Philips announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the adoption of telehealth across the industry, demonstrating its commitment to connecting care across acute, post-acute and home care settings.

June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during 2020-2024, progressing at a CAGR of almost 6% during the forecast period.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now